Bristol-Myers Squibb
BMY
BMY
2,356 hedge funds and large institutions have $104B invested in Bristol-Myers Squibb in 2020 Q4 according to their latest regulatory filings, with 286 funds opening new positions, 946 increasing their positions, 869 reducing their positions, and 108 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more capital invested
Capital invested by funds: $100B → $104B (+$3.72B)
0.37% less ownership
Funds ownership: 74.01% → 73.64% (-0.37%)
16% less funds holding in top 10
Funds holding in top 10: 93 → 78 (-15)
Holders
2,356
Holding in Top 10
78
Calls
$1.51B
Puts
$1.38B
Top Buyers
| 1 | +$618M | |
| 2 | +$368M | |
| 3 | +$311M | |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$239M |
| 5 |
Morgan Stanley
New York
|
+$237M |
Top Sellers
| 1 | -$744M | |
| 2 | -$507M | |
| 3 | -$430M | |
| 4 |
Two Sigma Advisers
New York
|
-$242M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$215M |